[{"address1": "7 Ha\u2019Eshel Street", "address2": "PO Box 3163", "city": "Caesarea", "zip": "3079504", "country": "Israel", "phone": "972 4 623 0333", "website": "https://www.icecure-medical.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.", "fullTimeEmployees": 71, "maxAge": 86400, "priceHint": 4, "previousClose": 0.7498, "open": 0.74, "dayLow": 0.71, "dayHigh": 0.74, "regularMarketPreviousClose": 0.7498, "regularMarketOpen": 0.74, "regularMarketDayLow": 0.71, "regularMarketDayHigh": 0.74, "beta": 2.899, "forwardPE": -2.8292308, "volume": 39249, "regularMarketVolume": 39249, "averageVolume": 419630, "averageVolume10days": 162010, "averageDailyVolume10Day": 162010, "bid": 0.6926, "ask": 0.7766, "bidSize": 100, "askSize": 100, "marketCap": 35264076, "fiftyTwoWeekLow": 0.52, "fiftyTwoWeekHigh": 1.57, "priceToSalesTrailing12Months": 10.810569, "fiftyDayAverage": 1.05974, "twoHundredDayAverage": 1.068065, "currency": "USD", "enterpriseValue": 24847072, "floatShares": 21112900, "sharesOutstanding": 47939200, "sharesShort": 243236, "sharesShortPriorMonth": 299759, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0050999997, "heldPercentInsiders": 0.56564, "heldPercentInstitutions": 0.0021, "shortRatio": 0.32, "shortPercentOfFloat": 0.0115, "impliedSharesOutstanding": 50743300, "bookValue": 0.243, "priceToBook": 3.0271604, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -14493000, "trailingEps": -0.32, "forwardEps": -0.26, "enterpriseToRevenue": 7.617, "enterpriseToEbitda": -1.663, "52WeekChange": -0.36, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ICCM", "underlyingSymbol": "ICCM", "shortName": "IceCure Medical Ltd.", "longName": "IceCure Medical Ltd", "firstTradeDateEpochUtc": 1629984600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2dee5847-d919-31fd-833b-0ca9a7ff1247", "messageBoardId": "finmb_29898934", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.7356, "targetHighPrice": 4.41, "targetLowPrice": 2.9, "targetMeanPrice": 3.33, "targetMedianPrice": 3.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 10966000, "totalCashPerShare": 0.229, "ebitda": -14940000, "totalDebt": 549000, "quickRatio": 2.71, "currentRatio": 3.392, "totalRevenue": 3262000, "debtToEquity": 4.718, "revenuePerShare": 0.071, "returnOnAssets": -0.44458, "returnOnEquity": -0.8615, "freeCashflow": -7460125, "operatingCashflow": -12436000, "revenueGrowth": 0.046, "grossMargins": 0.38289002, "operatingMargins": -4.91252, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]